ReNAissance is one of the projects selected by the Impact Santé program, an initiative led by Inserm as part of France 2030. The aim of this program is to support the most daring, high-impact health research, by funding projects that push back the boundaries of current science and medicine.
Team 3 from INCIT Lab Inserm U1302 (Nantes) is part of the Inserm Impact Santé project DARVAC "Development of vaccines offering innovative early protection against non-viral cancers" based on ghost (Dark) proteins. The project is led by Jerome Galon, with Michel...
INCIT was honored at the "Go Immuno" conference organized by Labex IGO in December. Margaux Verdon (team 1) was awarded the prize for best poster, while Gwenann Cadiou (team 3) won the prize for best oral communication!
Catherine Rabu (team 3) will present her HDR entitled: Antigènes de tumeurs issus de LongNonCoding RNA: identification, modes d'expression et utilisation thérapeutique on June 16 at 14.30, rooms 1, 2, 3 at IRS2, Nantes.
Dr. Etienne Meunier (Institute of Pharmacology & Structural Biology (IPBS) will give a seminar entitled: Emerging innate immune sensors in microbial detection, on June 12 at 2:00 pm - Rooms 1, 2, 3 - IRS2, Nantes
Dr Isabelle Satney (Centre Méditerranéen de Médecine Moléculaire) will give a seminar entitled: Study of the interaction between T cell metabolism and physical capacities in aged mice: transposition to humans, May 11 at 11:00 am - Rooms 1, 2, 3 - IRS2, Nantes
Dr Elena Menand Spirina (Institut de Cancérologie de l'Ouest) will give a seminar entitled: Learning to train and to explain a deep survival model with large scale ovarian cancer transcriptomic data, on April 13 at 14.30 - Amphi D. Escande at IRS-UN, Nantes
Dr. Guillaume Sarrabayrouse from UMR 8258 will give a seminar entitled: Evaluation of digestive homeostasis disturbances induced by recombinant erythropoietin treatment, on February 28 at 14.00 Rooms 1, 2, 3 at IRS2, Nantes
Dr. Karl Herbert Schaefer from the University of Kaiserslautern will give a seminar entitled: News from the Gut: how to investigate ENS and related diseases , on January 30 at 11.00 am Rooms 1, 2, 3 at IRS2, Nantes
The INCIT unit is pleased to announce that it has been awarded an ambitious European program on immunotherapy, bringing together 7 partners (including 2 biotechs) in 4 European countries. This program is coordinated by Frédéric ALTARE, Director of the UMR 1302, INCIT in Nantes. Project title: immunotherapy of inflammatory bowel diseases
Can't find what you want?